Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol-Reference-Cited by-同舟云学术

Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol

Published:2006-07-27 Issue:5 Volume:77 Page:365-371
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Sun Xiao-Fei,Zhen Zi-Jun,Lui Dong-Gen,Xia Yi,He You-Jian,Wang Zhi-Hui,Lin Jia-yu,Guan Zhong-Zhen

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2006.00735.x/fullpdf

Reference21 articles.

1. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group;Reiter;J Clin Oncol,1995

2. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group trial NHL-BFM90;Reiter;Blood,1999

3. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia;Patte;Blood,2001

4. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the children's cancer group experience;Cairo;Br J Haematol,2003

5. Intensive, very short-term Chemotherapy for advanced Burkitt's lymphoma in children;Spreafico;J Clin Oncol,2002

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma;Frontiers in Oncology;2021-04-21

2. Treatment results of modified bfm protocol in pediatric high-risk burkitt lymphoma;The Turkish Journal of Pediatrics;2021

3. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4;Pediatric Hematology and Oncology;2020-05-04

4. Science and health for all children with cancer;Science;2019-03-15

5. Optimizing outcomes for children with non‐Hodgkin lymphoma in low‐ and middle‐income countries by early correct diagnosis, reducing toxic death and preventing abandonment;British Journal of Haematology;2019-02-10